Benefits, limitations, and harm of local excision for rectal cancer

Annals of Surgical Oncology

Volumn 15, Issue 9, 2008, Pages 2628-2629

  Ziogas, D ^a   Tsekeris, P ^a   Fatourou, E ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; LAPAROSCOPIC SURGERY; LETTER; MULTIMODALITY CANCER THERAPY; QUALITY OF LIFE; RECTUM CANCER; RISK BENEFIT ANALYSIS;

CHEMOTHERAPY, ADJUVANT; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; RECTAL NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 50049133268     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9852-y     Document Type: Letter

References (34)

1. WE Enker HT Thaler ML Cranor 1995 Total mesorectal excision in the operative treatment of carcinoma of the rectum J Am Coll Surg 181 335 46
2. DH Roukos AM Kappas 2005 Perspectives in the treatment of gastric cancer Nat Clin Pract Oncol 2 98 107
3. DH Roukos 2002 Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9 220 1
4. M Clarke R Collins S Darby 2005 Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials Lancet 366 2087 106
5. DH Roukos S Murray E Briasoulis 2007 Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer Cancer Biol Ther 6 308 12
6. DH Roukos 2008 HER2 and response to paclitaxel in node-positive breast cancer N Engl J Med 358 197
7. DH Roukos 2008 Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies Expert Rev Mol Diagn 8 29 39
8. Liakakos T, Roukos DH. More controversy than ever-Challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol 2008 Jan 23 [Epub ahead of print] (DOI: 10.1245/s10434-007-9798-5 )
9. DH Roukos E Briasoulis 2007 Individualized preventive and therapeutic management of hereditary breast ovarian cancer Nat Clin Pract Oncol 4 578 90
10. Baik SH, Lee WJ, Rha KH, et al. Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc 2007 Nov 20 [Epub ahead of print]
11. T Borschitz D Wachtlin M Möhler 2008 Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer Ann Surg Oncol 15 712 20
12. DH Roukos M Fatouros E Tsianos 2006 Does a new model improve decisions about mismatch-repair genetic testing and Lynch syndrome identification? Nat Clin Pract Oncol 3 656 7
13. HT Lynch A de la Chapelle 2003 Hereditary colorectal cancer N Engl J Med 348 919 32
14. DH Roukos AM Kappas E Tsianos 2002 Role of surgery in the prophylaxis of hereditary cancer syndromes Ann Surg Oncol 9 607 9
15. DH Roukos NJ Agnanti E Paraskevaidis 2002 Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations Ann Surg Oncol 9 941 3
16. JA Norton CM Ham J Van Dam 2007 CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer Ann Surg 245 873 9
17. DH Roukos 2007 Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 357 1555 6 author reply 1556
18. M Fatouros G Baltoyiannis DH Roukos 2008 The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women with BRCA1/2 Mutations Ann Surg Oncol 15 21 33
19. NJ Agnantis E Paraskevaidis D Roukos 2004 Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance Ann Surg Oncol 11 1030 4
20. DH Roukos AM Kappas NJ Agnantis 2003 Perspectives and risks of breast-conservation therapy for breast cancer Ann Surg Oncol 10 718 21
21. M Fatouros DH Roukos I Arampatzis 2005 Factors increasing local recurrence in breast-conserving surgery Expert Rev Anticancer Ther 5 737 45
22. DH Roukos C Hottenrott A Encke 1994 Primary gastric lymphomas: a clinicopathologic study with literature review Surg Oncol 3 115 25
23. DH Roukos 2004 Early-stage gastric cancer: a highly treatable disease Ann Surg Oncol 11 127 9
24. E Briasoulis M Fatouros DH Roukos 2007 Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691 5
25. DH Roukos M Lorenz K Karakostas 2001 Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study Br J Cancer 84 1602 9
26. AM Kappas M Fatouros DH Roukos 2004 Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11 727 30
27. DH Roukos AM Kappas 2002 Targeting the optimal extent of lymph node dissection for gastric cancer J Surg Oncol 81 59 62
28. DH Roukos 1998 Extended lymphadenectomy in gastric cancer: when, for whom and why Ann R Coll Surg Engl 80 16 24
29. DH Roukos 2000 Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7 253 5
30. E Briasoulis T Liakakos L Dova 2006 Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer Expert Rev Anticancer Ther 6 931 9
31. DH Roukos 1999 Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer Ann Surg Oncol 6 46 56
32. DH Roukos M Lorenz A Encke 1998 Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study Surgery 123 573 8
33. DH Roukos 2000 Current status and future perspectives in gastric cancer management Cancer Treat Rev 26 243 55
34. DH Roukos 2008 Linking contralateral breast cancer with genetics Radiother Oncol 86 139 41